+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830858
Description Jump to:
The global whole exome sequencing market size is expected to reach USD 1.27 billion by 2030, registering a CAGR of 17.48% over the forecast period. One of the primary factors driving the market is the advancement in technology for whole exome sequencing. High throughput technology is becoming more widely used in clinical diagnostics and research which helps doctors to better understand the exome sequence disorders and made a treatment accordingly. Additionally, the rising prevalence of genetic conditions has enabled the adoption of whole exome sequencing for the investigation of protein coding regions and the derivation of valuable output about genetic variants.

Additionally, the significant increase in research including whole exomes is driven by the availability of data analysis and interpretation software. The use of these tools and software to examine genetic data is easy and it provides a fresh insight into the underlying causes of genetic abnormalities and diseases. For instance, in May 2022, Illumina’s subsidiary Grail, announced a partnership with the U.S. Department of Veterans Affairs, to provide their Galleri multi-cancer early detection test to U.S. veterans. This test utilizes whole exome sequences to detect multiple types of cancer in the early stages. This partnership exemplifies how the usage of whole exome sequencing and advanced data analysis tools can enable large-scale genomic research and transform the future of precision medicine.

The market has been significantly impacted by the COVID-19 pandemic. An example of how whole exomes have been used to better understand the virus and its dissemination is the COVID-19 Genomics UK Consortium study. The pandemic has also brought attention to the promise of exome sequence in the fight against infectious diseases, spurring additional investment in this field of study. The entire market is anticipated to develop in the upcoming years despite difficulties brought on by the pandemic in 2020.

Whole Exome Sequencing Market Report Highlights

  • By product, consumables segment dominated the market in 2022 with a share of 62.91%, due to higher demand for genetic testing and research which require a higher volume of consumables like kits, reagents, and other lab supplies
  • By technology, sequencing by synthesis segment dominated the market in 2022 with a share of 73.50%, due to higher accuracy and throughput limits, which make it a more popular choice for a wide range of applications
  • By workflow, sequencing segment dominated the market in 2022 with a share of 49.94%, as it is a very critical step and involves the generation of raw data. This has led to a higher demand for sequencing workflow in research and clinical applications
  • By application, drug discovery & development had a dominant presence in the market with a share of 48.18% in the year 2022, due to its ability to provide valuable output into the genetic basis of disease and drug response, and it helps to develop personalized and targeted therapies
  • By end-use, academic & research institutes segment held the largest market share of 47.32% in 2022, due to high investments in the field of genomic research and growing demand for the technology in the field of academics and research
  • North America established a strong regional position in the market with a 50.52% share in 2022 due to its highly developed healthcare infrastructure and favorable government policies


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Prevalence of Genetic Diseases
3.2.1.2. Technological Advancements in Sequencing Platforms and Data Analysis Tools
3.2.1.3. Decreasing Costs of Sequencing
3.2.2. Market Restraint Analysis
3.2.2.1. High Complexity and Costs Associated with Data Storage, Interpretation & Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Whole Exome Sequencing Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Whole Exome Sequencing Market: Technology Movement Analysis
5.2. Sequencing by Synthesis
5.2.1. Sequencing By Synthesis Market, 2018 - 2030 (USD Million)
5.3. ION Semiconductor Sequencing
5.3.1. ION Semiconductor Sequencing Market, 2018 - 2030 (USD Million)
5.4. Others
5.4.1. Other Technology Market, 2018 - 2030 (USD Million)
Chapter 6. Workflow Business Analysis
6.1. Whole Exome Sequencing Market: Workflow Movement Analysis
6.2. Pre-Sequencing
6.2.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
6.3. Sequencing
6.3.1. Sequencing Market, 2018 - 2030 (USD Million)
6.4. Data Analysis
6.4.1. Data Analysis Workflow Market, 2018 - 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Clinical Diagnostics
7.1.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
7.2. Drug Discovery & Development
7.2.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
7.3. Personalized Medicines
7.3.1. Personalized Medicines Market, 2018 - 2030 (USD Million)
7.4. Others
7.4.1. Other Application Market, 2018 - 2030 (USD Million)
Chapter 8. End-Use Business Analysis
8.1. Academic And Research Institutes
8.1.1. Academic And Research Institutes Market, 2018 - 2030 (USD Million)
8.2. Hospitals & Clinics
8.2.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
8.4. Others
8.4.1. Other End-use Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Whole Exome Sequencing Market Share By Region, 2022 & 2030
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. U.S. Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Canada Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.3. UK
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. UK Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.4. Germany
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Germany Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. France Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Italy Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Spain Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Denmark Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Sweden Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. Norway Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. SWOT Analysis
9.4.2. Asia Pacific Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Japan Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. China Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. India Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Australia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Thailand Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.8. South Korea
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Prevalence
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. South Korea Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Brazil Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Mexico Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Prevalence
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Argentina Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. South Africa Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Saudi Arabia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. UAE Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Target Disease Prevalence
9.6.6.3. Competitive Scenario
9.6.6.4. Regulatory Framework
9.6.6.5. Kuwait Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Illumina, Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Agilent Technologies, Inc
10.4.3.1. Overview
10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. BGI
10.4.4.1. Overview
10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. PacBio
10.4.5.1. Overview
10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Oxford Nanopore Technologies plc.
10.4.6.1. Overview
10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Azenta US Inc. (GENEWIZ)
10.4.7.1. Overview
10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. CD Genomics
10.4.8.1. Overview
10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Novogene Co, Ltd
10.4.9.1. Overview
10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Eurofins Genomics
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 3 Global whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 4 Global whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 6 Global whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 7 Global whole exome sequencing market, by region, 2018 - 2030 (USD Million)
Table 8 North America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 9 North America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 10 North America Whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 11 North America Whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 13 North America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 16 U.S. whole Exome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
Table 17 U.S. whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 18 U.S. whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 20 Canada whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 21 Canada whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 23 Canada whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 25 Europe whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 26 Europe whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 28 Europe whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 29 Europe whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 30 UK whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 31 UK whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 32 UK whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 33 UK whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 34 UK whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 35 Germany whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 36 Germany whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 37 Germany whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 38 Germany whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 39 Germany whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 40 France whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 41 France whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 42 France whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 43 France whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 44 France whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 45 Italy whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 46 Italy whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 47 Italy whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 48 Italy whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 49 Italy whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 50 Spain whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 51 Spain whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 52 Spain whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 53 Spain whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 54 Spain whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 55 Denmark whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 56 Denmark whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 57 Denmark whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 58 Denmark whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 59 Denmark whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 60 Sweden whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 61 Sweden whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 62 Sweden whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 63 Sweden whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 64 Sweden whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Norway whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 66 Norway whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 67 Norway whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 68 Norway whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 69 Norway whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 70 Asia Pacific whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 72 Asia Pacific whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 73 Asia Pacific whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 74 Asia Pacific whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 75 Asia Pacific whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 76 Japan whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 77 Japan whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 78 Japan whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 79 Japan whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 80 Japan whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 81 China whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 82 China whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 83 China whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 84 China whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 85 China whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 86 India whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 87 India whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 88 India whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 89 India whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 90 India whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 91 Australia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 92 Australia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 93 Australia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 94 Australia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 95 Australia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 96 Thailand whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 97 Thailand whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 98 Thailand whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 99 Thailand whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 100 Thailand whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 101 South Korea whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 102 South Korea whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 103 South Korea whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 104 South Korea whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 105 South Korea whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 106 Latin America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 107 Latin America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 108 Latin America whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 109 Latin America whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 110 Latin America whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 111 Latin America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 112 Brazil whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 113 Brazil whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 114 Brazil whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 115 Brazil whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 116 Brazil whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 117 Mexico whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 118 Mexico whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 119 Mexico whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 120 Mexico whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 121 Mexico whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 122 Argentina whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 124 Argentina whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 125 Argentina whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 126 Argentina whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 135 South Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 136 South Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 137 South Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 143 UAE whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 144 UAE whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 145 UAE whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 146 UAE whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 147 UAE whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 148 Kuwait whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 150 Kuwait whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 151 Kuwait whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 152 Kuwait whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Whole exome sequencing market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global whole exome sequencing market: Product movement analysis
Fig. 15 Global whole exome sequencing market, for instruments, 2018 - 2030 (USD Million)
Fig. 16 Global whole exome sequencing market, for consumables, 2018 - 2030 (USD Million)
Fig. 17 Global whole exome sequencing market, for services, 2018 - 2030 (USD Million)
Fig. 18 Global whole exome sequencing market: Technology movement analysis
Fig. 19 Global whole exome sequencing market, for sequencing by synthesis, 2018 - 2030 (USD Million)
Fig. 20 Global whole exome sequencing market, for ION semiconductor sequencing, 2018 - 2030 (USD Million)
Fig. 21 Global whole exome sequencing market, for other technology, 2018 - 2030 (USD Million)
Fig. 22 Global whole exome sequencing market: Workflow movement analysis
Fig. 23 Global whole exome sequencing market, for pre-sequencing, 2018 - 2030 (USD Million)
Fig. 24 Global whole exome sequencing market, for sequencing, 2018 - 2030 (USD Million)
Fig. 25 Global whole exome sequencing market, for data analysis, 2018 - 2030 (USD Million)
Fig. 26 Global whole exome sequencing market: Application movement analysis
Fig. 27 Global whole exome sequencing market, for clinical diagnostics, 2018 - 2030 (USD Million)
Fig. 28 Global whole exome sequencing market, for drug discovery & development, 2018 - 2030 (USD Million)
Fig. 29 Global whole exome sequencing market, for personalized medicine, 2018 - 2030 (USD Million)
Fig. 30 Global whole exome sequencing market, for other applications, 2018 - 2030 (USD Million)
Fig. 31 Global whole exome sequencing market: End-use movement analysis
Fig. 32 Global whole exome sequencing market, for academic & research institutes, 2018-030, (USD Million)
Fig. 33 Global whole exome sequencing market, for hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 34 Global whole exome sequencing market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
Fig. 35 Global whole exome sequencing market, for other end-use, 2018 - 2030 (USD Million)
Fig. 36 Regional marketplace: Key takeaways
Fig. 37 Regional outlook, 2022 & 2030
Fig. 38 Global whole exome sequencing market: Region movement analysis
Fig. 39 North America whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 40 U.S. whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 41 Canada whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 42 Europe whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 43 Germany whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 44 UK whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 45 France whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 46 Italy whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 47 Spain whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 48 Denmark whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 49 Sweden whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 50 Norway whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 52 Japan whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 53 China whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 54 India whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 55 Australia whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 56 South Korea whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 57 Thailand whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 58 Latin America whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 59 Brazil whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 60 Mexico whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 61 Argentina whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 62 Middle East and Africa whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 63 South Africa whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 64 Saudi Arabia whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 65 UAE whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 66 Kuwait whole exome sequencing market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc
  • BGI
  • PacBio
  • Oxford Nanopore Technologies plc.
  • Azenta US Inc. (GENEWIZ)
  • CD Genomics
  • Novogene Co, Ltd
  • Eurofins Genomics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 360.7 Million
Forecasted Market Value ( USD ) by 2030 $ 1270 Million
Compound Annual Growth Rate17.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Whole Exome Sequencing Global Market Report 2024 - Product Image

Whole Exome Sequencing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Whole Genome and Exome Sequencing Global Market Report 2024 - Product Image

Whole Genome and Exome Sequencing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Whole Exome Sequencing: Global Strategic Business Report - Product Image

Whole Exome Sequencing: Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Whole Exome Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Whole Exome Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 160 Pages
  • Global
From
Whole Exome Sequencing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Whole Exome Sequencing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 102 Pages
  • Global
From

About the Market

Exome sequencing is a type of genomics technology used to sequence the protein-coding regions of the genome, known as the exome. It is used to identify genetic variants associated with diseases, and to provide insights into the genetic basis of complex traits. Exome sequencing is a cost-effective alternative to whole-genome sequencing, as it focuses on the most biologically relevant regions of the genome. Exome sequencing is used in a variety of applications, including clinical diagnostics, drug discovery, and research. It is also used to identify rare genetic variants associated with diseases, and to provide insights into the genetic basis of complex traits. Exome sequencing is a rapidly growing market, with a number of companies offering services and products. Examples include Illumina, Thermo Fisher Scientific, BGI, and Genomics plc. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.